Skip to main content

Design Therapeutics, Inc.

DSGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001807120

No open-market purchases or sales by Design Therapeutics, Inc. insiders were filed in the last 90 days; 136 institutions reported holding it in 13F filings for Q2 2026, worth $626.4M in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Design Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
117
+23 vs. Q3 2025
Shares held
38.1M
+3.63M (+10.5%) vs. Q3 2025
Total value
$357.6M
+$97.9M (+37.7%) vs. Q3 2025
New holders
31
39 more added
Sold out
8
28 more reduced

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting DSGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 117 institutions
Q1 2021: 43 institutionsQ2 2021: 50 institutionsQ3 2021: 52 institutionsQ4 2021: 60 institutionsQ1 2022: 63 institutionsQ2 2022: 74 institutionsQ3 2022: 79 institutionsQ4 2022: 83 institutionsQ1 2023: 96 institutionsQ2 2023: 97 institutionsQ3 2023: 87 institutionsQ4 2023: 88 institutionsQ1 2024: 93 institutionsQ2 2024: 95 institutionsQ3 2024: 100 institutionsQ4 2024: 95 institutionsQ1 2025: 98 institutionsQ2 2025: 93 institutionsQ3 2025: 95 institutionsQ4 2025: 117 institutionsQ1 2026: 125 institutionsQ2 2026: 136 institutions
Value heldQ4 2025: $357.6M
Q1 2021: $755.2MQ2 2021: $546.2MQ3 2021: $414.8MQ4 2021: $773.1MQ1 2022: $613.7MQ2 2022: $541.7MQ3 2022: $667.2MQ4 2022: $414.2MQ1 2023: $223.3MQ2 2023: $244.4MQ3 2023: $77.6MQ4 2023: $84.0MQ1 2024: $123.9MQ2 2024: $107.5MQ3 2024: $172.3MQ4 2024: $206.5MQ1 2025: $133.0MQ2 2025: $116.4MQ3 2025: $259.7MQ4 2025: $357.6MQ1 2026: $404.1MQ2 2026: $626.4M
Institutions holding DSGN and their total value by quarter
QuarterHoldersValue
Q2 2026136$626.4M
Q1 2026125$404.1M
Q4 2025117$357.6M
Q3 202595$259.7M
Q2 202593$116.4M
Q1 202598$133.0M
Q4 202495$206.5M
Q3 2024100$172.3M
Q2 202495$107.5M
Q1 202493$123.9M
Q4 202388$84.0M
Q3 202387$77.6M
Q2 202397$244.4M
Q1 202396$223.3M
Q4 202283$414.2M
Q3 202279$667.2M
Q2 202274$541.7M
Q1 202263$613.7M
Q4 202160$773.1M
Q3 202152$414.8M
Q2 202150$546.2M
Q1 202143$755.2M

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Design Therapeutics, Inc.; share changes are against Q3 2025.

Institutions holding DSGN in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Acadian Asset Management LLC612,768$5.74M0.01%−4,721−0.8%Reduced
State Street Corp647,636$6.07M0.00%+13,239+2.1%Added
Geode Capital Management, LLC679,590$6.38M0.00%−16,023−2.3%Reduced
Morgan Stanley702,306$6.59M0.00%+526,315+299.1%Added
FMR LLC771,268$7.23M0.00%+30,419+4.1%Added
Kynam Capital Management, LP784,606$7.36M0.48%−244,973−23.8%Reduced
Woodline Partners LP944,039$8.86M0.03%+331,327+54.1%Added
Driehaus Capital Management LLC1,179,817$11.1M0.08%+103,581+9.6%Added
Ra Capital Management, L.P.1,461,381$13.7M0.14%+985,682+207.2%Added
Almitas Capital LLC1,530,435$14.4M3.16%00.0%Unchanged
Vivo Capital, LLC1,612,903$15.1M0.98%+1,612,903New
Vanguard Group Inc1,630,910$15.3M0.00%+187,209+13.0%Added
BlackRock, Inc.2,117,156$19.9M0.00%+72,768+3.6%Added
Baker Bros. Advisors LP2,233,099$20.9M0.12%+520,217+30.4%Added
Logos Global Management LP2,500,000$23.4M1.56%−1,155,000−31.6%Reduced
Point72 Asset Management, L.P.5,372,004$50.4M0.08%+2,031,452+60.8%Added
Sr One Capital Management, LP6,526,476$61.2M8.67%00.0%Unchanged
Tang Capital Management LLC0$00.00%−1,780,975−100.0%Sold out
MPM Oncology Impact Management LP0$00.00%−555,187−100.0%Sold out
DLD Asset Management, LP0$00.00%−50,000−100.0%Sold out
HRT Financial LP0$00.00%−31,903−100.0%Sold out
Sphera Funds Management Ltd.0$00.00%−21,918−100.0%Sold out
Intech Investment Management LLC0$00.00%−14,155−100.0%Sold out
Rise Advisors, LLC0$00.00%−130−100.0%Sold out
Versant Capital Management, Inc0$00.00%−71−100.0%Sold out
Point72 Asia (Singapore) Pte. Ltd.––––Not filed